Page last updated: 2024-11-06

dioxadet

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID48858
CHEMBL ID2003457
SCHEMBL ID9452629
MeSH IDM0120004

Synonyms (29)

Synonym
(5-((4,6-di(1-aziridinyl)-1,3,5-triazin-2-yl)amino)-2,2-dimethyl-1,3-dioxan-5-yl)methanol
s-triazine, 4,6-diaziridinyl-2-(2,2-dimethyl-5-hydroxymethyl-m-dioxan-5-ylamino)-
m-dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-s-triazinylamino)-
2,2-dimethyl-5-(4,6-diaziridinyl-2-s-triazinylamino)-m-dioxane-5-methanol
[5-[[4,6-bis(aziridin-1-yl)-1,3,5-triazin-2-yl]amino]-2,2-dimethyl-1,3-dioxan-5-yl]methanol
1,3-dioxane-5-methanol, 5-{[4,6-bis(1-aziridinyl)-1,3,5-triazin-2-yl]amino}-2,2-dimethyl-
NCI60_002242
1, 5-[[4,6-bis(1-aziridinyl)-1,3,5-triazin-2-yl]amino]-2,2-dimethyl-
nsc-275656
m-dioxane-5-methanol,2-dimethyl-5-(4,6-diaziridinyl-2-s-triazinylamino)-
dioxadet
wln: t6o cotj b1 b1 e1q em- bt6n cn enj d- at3ntj& f- at3ntj
2,6-diaziridinyl-2-s-triazinylamino)-m-dioxane-5-methanol
67026-12-4
s-triazine,6-diaziridinyl-2-(2,2-dimethyl-5-hydroxymethyl-m-dioxan-5-ylamino)-
nsc275656
brn 0577461
5-equatorial-((4,6-bis(1-aziridinyl)-s-triazin-2-yl)amino)-2,2-dimethyl-m-dioxane-5-methanol
m-dioxane-5-methanol, 5-equatorial-((4,6-bis(1-aziridinyl)-s-triazin-2-yl)amino)-2,2-dimethyl
nsc 275656
SCHEMBL9452629
unii-3ne0tv9szs
3ne0tv9szs ,
2,4-bis(1-aziridinyl)-6-(2,2-dimethyl-5-hydroxymethyl-1,3-dioxan-5-yl)amino-1,3,5-triazine
CHEMBL2003457
DTXSID30217245
2,4-bis-(aziridinyl)-6-(2,2-dimethyl-5-oxymethyl-1,3-dioxan-5-yl)amino-1,3,5-triazine
1,3-dioxane-5-methanol, 5-((4,6-bis(1-aziridinyl)-1,3,5-triazin-2-yl)amino)-2,2-dimethyl-
5-((4,6-bis(1-aziridinyl)-1,3,5-triazin-2-yl)amino)-2,2-dimethyl-1,3-dioxane-5-methanol

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Dioxadet treatment of mice and rats bearing intracranially-transplanted L1210 leukemia and glioma 35 was followed by a 38-48 and 29% increase in survival, respectively."( [Effect of dioxadet on tumors transplanted to the brain].
Khrapova, TN; Kil'maeva, NE; Korsakov, MV; Kraĭz, BO; Stukov, AN, 1986
)
1.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's2 (13.33)18.2507
2000's1 (6.67)29.6817
2010's9 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]